SCOT-HEART 2 试验的原理与设计:CT 血管成像用于预防心肌梗死
冠状动脉疾病仍是全球主要死因,当前预防策略主要依赖概率风险评分但缺乏随机对照试验证据。SCOT-HEART 2 试验旨在确定采用 CT 冠状动脉血管成像筛查是否比心血管风险评分更能指导一级预防治疗并降低心肌梗死风险。
要点
- SCOT-HEART 2 试验旨在比较 CT 冠状动脉血管成像筛查与心血管风险评分指导一级预防治疗的临床有效性。
- 既往试验显示,CT 冠状动脉血管成像发现冠状动脉疾病的患者更可能启动预防治疗且心脏事件发生率更低。
- 该试验设计背景是概率风险评分缺乏随机对照试验证明其指导预防的疗效。
核心结论
- SCOT-HEART 2 试验旨在确定采用 CT 冠状动脉血管成像筛查是否比心血管风险评分在指导一级预防治疗和降低心肌梗死风险方面更临床有效。
研究设计与样本
- SCOT-HEART 2(苏格兰心脏计算机断层扫描 2)试验,设计为随机对照试验,比较 CT 冠状动脉血管成像筛查与心血管风险评分指导一级预防治疗的效果。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Coronary artery disease continues to be the leading cause of death globally. Identifying patients who are at risk of coronary artery disease remains a public health priority. At present, the focus of cardiovascular disease prevention relies heavily on probabilistic risk scoring despite no randomized controlled trials demonstrating their efficacy. The concept of using imaging to guide preventative therapy is not new, but has previously focused on indirect measures such as carotid intima-media thickening or coronary artery calcification. In recent trials, patients found to have coronary artery disease on computed tomography (CT) coronary angiography were more likely to be started on preventative therapy and had lower rates of cardiac events. This led to the design of the SCOT-HEART 2 (Scottish Computed Tomography of the Heart 2) trial, which aims to determine whether screening with the use of CT coronary angiography is more clinically effective than cardiovascular risk scoring to guide the use of primary preventative therapies and reduce the risk of myocardial infarction.
引用
- McDermott M, Meah MN, Khaing P, et al. Rationale and Design of SCOT-HEART 2 Trial: CT Angiography for the Prevention of Myocardial Infarction. JACC Cardiovasc Imaging. 2024. PMID: 39001735. doi:10.1016/j.jcmg.2024.05.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。